HOME
SEARCH
RSS FEED
SUBSCRIBE
A New Mouse Monoclonal Antibody Against Human Microphthalmia Transcription Factor (MITF)
Case ID:
TAB-1365
Web Published:
12/6/2022
Description:
Micropthalmia Transcription Factor (MITF) plays an important role in melanocyte development and melanoma growth. MITF is important for embryonic development, regulating the generation of pigment cells and formation of melanomas and other tumors. MITF is made in various isoforms that may play unique roles for different organs during different developmental periods. Additionally, tissue MITF levels can serve as a molecular marker for the diagnosis of metastatic melanoma and therapeutic response.
This technology involves the generation of several novel mouse monoclonal antibodies against a sub-domain of an MITF fragment that is cleaved during cell death. Importantly, these antibodies cross-react with human MITF. The antibody was raised by immunizing mice that are incapable of producing the MITF sub-domain used as the antigen. Three (3) different "clones" of these antibodies are currently available and their corresponding hybridoma names are 6A5 (IgG1), 1D2 (IgG2a) and 3D1 (IgG2a).
Patent Information:
Title
App Type
Country
Serial No.
Patent No.
File Date
Issued Date
Expire Date
Patent Status
Direct Link:
https://nih.technologypublisher.com/tech/A_New_Mouse_Monoclonal_Antibody_Agai nst_Human_Microphthalmia_Transcription_Factor_(MITF)
Category(s):
Licensing
Materials Available
Oncology
Research Materials
Bookmark this page
Download as PDF
For Information, Contact:
Inteum Admin
NIH Technology Transfer
Inventors:
Wen Fang Liu
Hideki Murakami
Heinz Arnheitter
Keywords:
ANTIBODY
CANCER
CC2XXX
CCXXXX
CXXXXX
factor
Human
Microphthalmia
MITF
monoclonal
Mouse
RELATED
transcription
Home
|
Search
|
RSS
|
Subscribe
© 2025. All Rights Reserved. Powered by
Inteum